| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0bd6ce9b500a74e8af7cea584f28b8f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 |
| filingDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e843ad8fcd4a7265ba98f675fe3a991
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb9b197f7656bb35141d53eba57c79fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40f4aa47553bdaa83795aba9353f5de4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f700d995a07eb095a71a41033bea2c90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b16c57c1ab9293b8dc700fbba95349 |
| publicationDate |
2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105770889-A |
| titleOfInvention |
Use of binding molecules specifically binding to brain-derived neurotrophic factor precursor protein |
| abstract |
The present invention relates to the application of binding molecules specifically binding to brain-derived neurotrophic factor precursor protein (proBDNF). The present invention discovers for the first time that proBDNF is an important target for treating autoimmune diseases, and binding molecules specifically binding to proBDNF have significant alleviating or therapeutic effects on autoimmune diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112961865-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112961865-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3677280-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019042282-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109422805-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11479603-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020531041-A |
| priorityDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |